Drug Shortage Report for GLUCAGON
| Report ID | 257924 |
| Drug Identification Number | 02243297 |
| Brand name | GLUCAGON |
| Common or Proper name | zxcvxz |
| Company Name | ELI LILLY CANADA INC |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | GLUCAGON |
| Strength(s) | 1MG |
| Dosage form(s) | POWDER FOR SOLUTION KIT |
| Route of administration | SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR |
| Packaging size | ZC |
| ATC code | H04AA |
| ATC description | GLYCOGENOLYTIC HORMONES |
| Reason for shortage | Shortage of an active ingredient. |
| Anticipated start date | 2024-01-15 |
| Actual start date | |
| Estimated end date | Unknown |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2026-01-05 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | EXCHANGE TOWER, 130 KING STREET WEST TORONTO, ONTARIO CANADA M5X 1B1 |
| Company contact information | Lilly Canada’s Customer Response Centre 1-888-545-5972. |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v3 | 2026-01-05 | English | Compare |
| v2 | 2026-01-05 | French | Compare |
| v1 | 2026-01-05 | English | Compare |
Showing 1 to 3 of 3